O/T: I have just concluded my final accumulation of GTCB. short of an unwarranted down-spike towards $1, I will not need to add further.
I spent the better part of this weekend reviewing every possible tidbit of info.
On a risk-adjusted basis, the current market cap is absolutely ridiculous in the biotech space. This will require patience; however, by end CY 2008, the market's myopic view will have changed immeasurably.
This is purely based on what we know TODAY. Any new collaboration agreements or acquistion of GTCB news will merely accelerate the timeline.
Instead of looking for an overnight 10-bagger, GTCB is a sure 5-bagger plus by YE 2008.
The William Tells out there are free to empty their quivers and blow darts at my thesis on this one.
"Illegitimacy is something we should talk about in terms of not having it."
- Dan Quayle